CapsoVision Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	13.89	13.55	11.76	9.75
Revenue Growth	10.99%	15.29%	20.54%	-
Cost of Revenue	6.82	6.38	5.38	4.26
Gross Profit	7.07	7.17	6.38	5.49
Selling, General & Admin	15.31	14.22	11.17	7.51
Research & Development	21.56	18.31	15.12	9.33
Operating Expenses	36.87	32.53	26.29	16.84
Operating Income	-29.8	-25.36	-19.92	-11.35
Interest & Investment Income	0.37	0.27	0.03	0.05
Other Non Operating Income (Expenses)	-0.02	-0.04	0	0
EBT Excluding Unusual Items	-29.45	-25.13	-19.89	-11.29
Other Unusual Items	-0.36	-0.16	-	-
Pretax Income	-29.81	-25.29	-19.89	-11.29
Income Tax Expense	0.02	0.02	0.01	0.01
Net Income	-29.83	-25.32	-19.9	-11.31
Net Income to Common	-29.83	-25.32	-19.9	-11.31
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	48	25	2	2
Shares Outstanding (Diluted)	48	25	2	2
Shares Change	2118.22%	1115.57%	13.70%	-
EPS (Basic)	-0.62	-1.03	-9.85	-6.36
EPS (Diluted)	-0.62	-1.03	-9.85	-6.36
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-27.89	-22.95	-20.24	-11.56
Free Cash Flow Per Share	-0.58	-0.94	-10.02	-6.50
Gross Margin	50.88%	52.92%	54.24%	56.30%
Operating Margin	-214.51%	-187.08%	-169.42%	-116.34%
Profit Margin	-214.74%	-186.77%	-169.26%	-115.91%
Free Cash Flow Margin	-200.77%	-169.35%	-172.20%	-118.49%
EBITDA	-29.57	-25.14	-19.71	-11.21
EBITDA Margin	-212.90%	-185.49%	-167.67%	-114.90%
D&A For EBITDA	0.22	0.22	0.21	0.14
EBIT	-29.8	-25.36	-19.92	-11.35
EBIT Margin	-214.51%	-187.08%	-169.42%	-116.34%

SEC Filings: 10-K · 10-Q